Emerging Threats in Citrobacter Nosocomial Infections: Mechanisms of Virulence and Resistance
Journal of Communicable Diseases · 30.06.2026 · 58 (2) · 143-151
DOI: 10.24321/0019.5138.202640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Communicable Diseases, online erschienen am 30.06.2026. Verfasst von Ramya Ramadoss.
Abstract (Originalsprache)
Citrobacter species, especially Citrobacter freundii, have emerged as important nosocomial pathogens over the past decade. Rising rates of multidrug resistance (including extended-spectrum beta-lactamases (ESBLs) and carbapenemases) and documented hospital outbreaks have heightened clinical concern. This review consolidates recent literature on the aspects of epidemiology, clinical manifestations, virulence and resistance mechanisms in hospital-acquired Citrobacter infections. Most Citrobacter infections are nosocomial infections, with urinary tract, bloodstream, and intra-abdominal infections being predominant. Citrobacter species possess multiple virulence factors like adhesins, fimbriae, biofilm capability and Type VI secretion systems (T6SS), that facilitate colonisation, persistence and host interaction. Intrinsic chromosomal AmpC beta-lactamases and increasing acquisition of plasmid-mediated ESBLs and carbapenemases along with tripartite efflux pumps drive the emergence of multidrug-resistant (MDR) phenotypes. Environmental reservoirs for Citrobacter species and mobile genetic elements increase nosocomial transmission. Therapeutic management is increasingly challenging with emergence of newer beta -lactam/beta-lactamase inhibitor combinations. Siderophore cephalosporins could be potential inhibitors for carbapenemase-producing isolates, though interpretation of susceptibility testing remains essential. Effective nosocomial infection prevention requires strict adherence to hand hygiene, intubation device care, decontamination of hospital environment, and antimicrobial stewardship. Despite growing awareness, substantial knowledge gaps persist, particularly regarding molecular mechanisms behind virulence, optimal treatment pathways to reduce resistant infections, and cost-effective surveillance strategies. Citrobacter species is an emerging opportunistic pathogen with a dual challenge of virulence and resistance. This emphasizes the urgency to prioritize genomic surveillance, diagnostics and stewardship-informed therapies to address the clinical and public health impact.Keywords: Nosocomial infections, Opportunistic pathogens, Citrobacter, Antimicrobial resistance, Carbapenemase DOI: https://doi.org/10.24321/0019.5138.202640 How to cite this article:Ramadoss R, Moovarkumudalvan B, Lakshmanan D, Pradeep J, Bilal M I, Saravanan S K. Emerging Threats in Citrobacter Nosocomial Infections: Mechanisms of Virulence and Resistance. J Commun Dis. 2026;58(2):143-151.
Zitieren
APA
Ramadoss, R. (2026). Emerging Threats in Citrobacter Nosocomial Infections: Mechanisms of Virulence and Resistance. Journal of Communicable Diseases, 58(2), 143-151. https://doi.org/10.24321/0019.5138.202640
Vancouver
Ramadoss R. Emerging Threats in Citrobacter Nosocomial Infections: Mechanisms of Virulence and Resistance. Journal of Communicable Diseases. 2026;58(2):143-151. doi:10.24321/0019.5138.202640
BibTeX
@article{Ramadoss2026,
author = {Ramadoss, Ramya},
title = {Emerging Threats in Citrobacter Nosocomial Infections: Mechanisms of Virulence and Resistance},
journal = {Journal of Communicable Diseases},
year = {2026},
volume = {58},
number = {2},
pages = {143--151},
doi = {10.24321/0019.5138.202640}
}
EUVIMED